TREAT - 医索

找到约 157 条结果

WU-NK-101, an enhanced memory natural killer (NK) cell therapy, with cetuximab (Ctx) for the treatment of advanced colorectal cancer

医客学院 - 会议报告集

Trifluridinetipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer The phase 3 randomized SU

医客学院 - 会议报告集

Tislelizumab versus sorafenib in first-line treatment of unresectable hepatocellular carcinoma Impact on health-related quality

医客学院 - 会议报告集

STELLAR-303 A phase 3 study of XL092 in combination with atezolizumab versus regorafenib in patients with previously treated CRC

医客学院 - 会议报告集

Rationale 305 Phase 3 study of tislelizumab plus chemotherapy vs placebo plus chemotherapy as first-line treatment (1L) of GC GEJC

医客学院 - 会议报告集

Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for GCGEJCEAC 3-year follow-up from CheckMate 649

医客学院 - 会议报告集

Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimumab (IPI) vs chemo as first-line (1L) treatment for ESCC

医客学院 - 会议报告集

Nanvuranlat, an L-type amino acid transporter (LAT1) inhibitor for patients with pretreated advanced refractory biliary tract cancer

医客学院 - 会议报告集

Nab-paclitaxel plus anti–PD-1 antibody as second-line treatment for advanced biliary tract cancer An investigator-initiated phase 2

医客学院 - 会议报告集

LEANOX Lean body mass normalization of oxaliplatin-based chemotherapy for patients with stage III colon cancer treated in adjuvant

医客学院 - 会议报告集

今日实时热搜